AndroGel Lawsuit Alleges Manufacturer Illegally Blocked Generic Versions, Bernstein Liebhard LLP Rep

The Firm is evaluating testosterone lawsuits on behalf of men who allegedly suffered serious cardiovascular side effects due to their use of AndroGel and other low testosterone therapies. New York, New York (PRWEB) September 09, 2014 The Federal Trade Commission (FTC) has filed an AndroGel lawsuit (http://www.testosteronelawsuitcenter.com/androgel-lawsuit/) that alleges AbbVie, Teva Pharmaceuticals Industries Ltd., and Besins Healthcare, Inc. illegally blocked lower-cost generic versions of the testosterone treatment from coming to market, Bernstein Liebhard LLP reports. According to the c
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories